Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder
- First Posted Date
- 2024-08-05
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Proniras Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT06538558
- Locations
- 🇺🇸
Indiana University School of Medicine, Indianapolis, Indiana, United States
© Copyright 2025. All Rights Reserved by MedPath